MH
Highly rated in
11
conditions
Highly rated in
11
conditions
Check Dr. Michael R. Harrison's experience treating your condition:
About Dr. Michael R. Harrison

Michael Harrison is an Oncologist and a Hematologist Oncology expert in Durham, North Carolina. Harrison has been practicing medicine for over 19 years and is highly rated in 11 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Chromophobe Renal Cell Carcinoma, Endoscopy, and Orchiectomy. He is licensed to treat patients in Wisconsin and North Carolina. Harrison is currently accepting new patients.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael R. Harrison it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Michael R. Harrison accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Bright Health
  •  Cigna
  •  Aetna

Call to see if your plan is accepted.
Locations
20 Duke Medicine Cir, Durham, NC 27710
Background & Education
Graduate Institution
Tulane University School Of Medicine, 2004
Specialties
Oncology
Hematology Oncology
Hematology
Licenses
Internal Medicine in WI
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Phase II, Open-Label Randomized Study of Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer (SPARC)
Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
View 8 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors